Vaxcyte enters final stage of Phase II pneumococcal vaccine trial in infants
VAX-31’s safety, tolerability, and immunogenicity are being assessed in this trial on healthy infants. Vaxcyte anticipat ...
Hosted on MSN10d
Pfizer's Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales
Pfizer PFE reported fourth-quarter 2024 adjusted earnings per share of 63 cents, which beat the Zacks Consensus Estimate of ...
MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive
The Committee for Medicinal Products for Human Use recommends approval for Merck's pneumococcal 21-valent conjugate vaccine, ...
SheKnows21d
11 Things All Kids Should Be Able To Do by Age 15
The teen years are no joke. Many parents of 15-year-old kids are constantly hearing from their teens how their friends get to do so much more than they are allowed to do and how they are being ...
Insider Monkey28d
15 Best Cheap Stocks to Buy for 2025
Key pipeline assets include the CDK4 inhibitor, the SV and PD-L1 ADCs, and the next-generation Prevnar vaccine, all of which have the potential to be blockbuster products. Pfizer Inc. (NYSE ...